| 000 | 01816 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515211330.0 | ||
| 264 | 0 | _c20100520 | |
| 008 | 201005s 0 0 eng d | ||
| 022 | _a1873-2968 | ||
| 024 | 7 |
_a10.1016/j.bcp.2010.02.019 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBright, Sandra A | |
| 245 | 0 | 0 |
_aSequential treatment with flavopiridol synergistically enhances pyrrolo-1,5-benzoxazepine-induced apoptosis in human chronic myeloid leukaemia cells including those resistant to imatinib treatment. _h[electronic resource] |
| 260 |
_bBiochemical pharmacology _cJul 2010 |
||
| 300 |
_a31-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aBenzamides |
| 650 | 0 | 4 | _aDown-Regulation |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aFlavonoids _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImatinib Mesylate |
| 650 | 0 | 4 | _aInhibitor of Apoptosis Proteins |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
| 650 | 0 | 4 |
_aMicrotubule-Associated Proteins _xmetabolism |
| 650 | 0 | 4 |
_aOxazepines _xpharmacology |
| 650 | 0 | 4 |
_aPiperazines _xpharmacology |
| 650 | 0 | 4 |
_aPiperidines _xpharmacology |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aPyrimidines _xpharmacology |
| 650 | 0 | 4 |
_aPyrroles _xpharmacology |
| 650 | 0 | 4 | _aSurvivin |
| 700 | 1 | _aCampiani, Giuseppe | |
| 700 | 1 | _aDeininger, Michael W | |
| 700 | 1 | _aLawler, Mark | |
| 700 | 1 | _aWilliams, D Clive | |
| 700 | 1 | _aZisterer, Daniela M | |
| 773 | 0 |
_tBiochemical pharmacology _gvol. 80 _gno. 1 _gp. 31-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bcp.2010.02.019 _zAvailable from publisher's website |
| 999 |
_c19573453 _d19573453 |
||